Schonfeld Strategic Advisors’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.4K | Buy |
11,261
+80
| +0.7% | +$152 | ﹤0.01% | 1834 |
|
|
2025
Q1 | $79.3K | Sell |
11,181
-35,247
| -76% | -$250K | ﹤0.01% | 1911 |
|
|
2024
Q4 | $1.02M | Sell |
46,428
-17,599
| -27% | -$387K | 0.01% | 1042 |
|
|
2024
Q3 | $1.29M | Buy |
64,027
+21,704
| +51% | +$436K | 0.01% | 944 |
|
|
2024
Q2 | $736K | Buy |
42,323
+11,823
| +39% | +$206K | ﹤0.01% | 1211 |
|
|
2024
Q1 | $1.27M | Buy |
30,500
+12,190
| +67% | +$508K | 0.01% | 977 |
|
|
2023
Q4 | $461K | Sell |
18,310
-1,225
| -6% | -$30.8K | ﹤0.01% | 1234 |
|
|
2023
Q3 | $639K | Sell |
19,535
-13,255
| -40% | -$433K | 0.01% | 1023 |
|
|
2023
Q2 | $1.91M | Sell |
32,790
-1,777
| -5% | -$103K | 0.02% | 763 |
|
|
2023
Q1 | $902K | Buy |
34,567
+4,724
| +16% | +$123K | 0.01% | 984 |
|
|
2022
Q4 | $889K | Buy |
+29,843
| New | +$889K | 0.01% | 1204 |
|